Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-10-18
1987-04-14
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514316, 514330, 514355, A61K 31445, A61K 3144
Patent
active
046579176
ABSTRACT:
A pharmaceutical composition in unit dosage form suitable for administration to an animal in need thereof comprising a pharmaceutically acceptable carrier and an amount sufficient to inhibit blood platelet aggregation of a compound selected from the group consisting of:
REFERENCES:
Lasslo, J. Org. Chem., vol. 22, Jul., (1957), pp. 837-839.
Lasslo, J. Org. Chem., vol. 21, (1956), pp. 958-959.
Beasley, J. Med. Chem., vol. 7, (1964), pp. 698-701.
Quintana, J. Med. Chem., vol. 10, (1967), pp. 1178-1180.
Quintana, J. Pharm., Sci., vol. 52, Dec. 1963, pp. 1186-1188.
Quintana, J. Pharm. Sci., vol. 54, May 1965, pp. 785-787.
Quintana, Throm. Res., vol. 24, (1981), pp. 379-395.
Quintana, Throm. Res., vol. 22, (1981), pp. 665-680.
Quintana, Chem.-Biol. Interactions, vol. 38, (1982), pp. 135-144.
Quintana, Biophys. J., vol. 37, Jan. 1982, pp. 130-133.
Dugdale Marion
Lasslo Andrew
Quintana Ronald P.
Research Corporation
Waddell Frederick E.
LandOfFree
Platelet aggregation inhibitory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibitory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785978